Various Ways to Enhance the Results of Maxillary Sinus Augmentation Procedures by Jun-Beom Park
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
  
1 
Various Ways to Enhance the Results of 
Maxillary Sinus Augmentation Procedures 
Jun-Beom Park  
Department of Molecular Medicine and Biopharmaceutical Sciences,  
Graduate School of Convergence Science and Technology,  
Seoul National University, Seoul, 
Korea 
1. Introduction 
The placement of dental implants in the distal edentulous maxillary region is challenging 
due to the significant resorption following tooth extraction and the pneumatization of the 
maxillary sinus (Tadjoedin et al., 2003). Maxillary sinus augmentation is a well-established 
procedure for functional rehabilitation of partially or completely edentulous patients, as 
demonstrated by Boyne and James (1980) (Boyne and James 1980) (Figures 1-4). The survival 
rate for implants placed in graft sinuses showed comparable results to those generally 
reported for implants placed in pristine bone in the non-grafted posterior maxilla (Wallace 
and Froum 2003). 
 
 
 
 
 
 
 
 
Fig. 1. Preoperative clinical view. 
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Fig. 2. Buccal view after elevation of sinus membrane. 
 
 
Fig. 3. Clinical view after application of graft material. 
 
 
Fig. 4. The lateral wall is covered with a membrane. 
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Autogenous bone obtained from various donor sites from the patients performed with good 
results in bone regeneration and served as the gold standard (Tadjoedin et al., 2003). 
Various bone-grafting materials are being used in sinus augmentation including freeze-
dried bone allograft (Avila et al., 2010), bovine xenograft (Chaushu et al., 2009), and 
alloplastic material (Bae et al., 2010) as an alternative or supplement to autogenous bone. 
Sinus augmentation procedures are highly predictable, with many studies reporting over 
95% success (Del Fabbro et al., 2008). However, sinus augmentation may be influenced by 
the choice of graft material and implant surface micromorphology (Del Fabbro et al., 2008), 
and controversies still exist related to the most suitable way to perform sinus augmentation. 
2. Type of graft 
2.1 Autogenous graft 
Although autogenous bone grafting is still the gold standard, according to the clinical 
results (Nkenke and Stelzle 2009), it is considered to have osteoinductive and 
osteoconductive properties, and it is known to contain growth factors (Turhani et al., 2005). 
Autogenous corticocancellous bone cores can be obtained intraorally or extraorally 
(Galindo-Moreno et al., 2007), however, this requires an additional second surgical donor 
site and additional morbidity (Park 2010). 
A bone trap may be used to harvest bone debris during implant preparation, with 
additional bone collected by further drilling adjacent to the implant sites or by using a bone 
scraper to harvest cortical bone chips from the zygomatic buttress and from the lateral sinus 
wall before opening a bony window (Johansson et al., 2010). By using this approach, the 
autogenous bone can be achieved adjacent to the surgical site without the need for a remote 
second surgical donor site and additional morbidity (Park 2010). Furthermore, the amount 
of autogenous bone graft available for harvesting is limited and may be insufficient to fill 
large osseous defects (Mirzayan et al., 2001). Due to the complications associated with 
harvesting autogenous bone and its limited supply, many surgeons have sought bone-graft-
substitute materials (Mirzayan et al., 2001). 
2.2 Allograft 
Allograft has been used for grafting in multiple intraoral applications such as periodontics 
(infrabony defects), oral surgery (extraction sites), and implant dentistry (ridge 
augmentation) (Froum et al., 2006). Allografts are bony tissue from a donor of the same 
species and they are known to contain no viable cells (Hallman and Thor 2008). This 
allograft may be prepared by demineralization of the bone in hydrochloric acid to expose 
bone morphogenetic protein and this demineralized freeze-dried bone allograft may be 
considered to have osteoconductivity and osteoinductivitiy (Kalish et al., 2008). 
Atrophic maxillary floor augmentations were performed by mineralized human bone 
allograft in sinuses of different size, and the results showed that this material produced 
satisfactory bone formation (Maria Soardi et al., 2010). Histologic evaluation using 
mineralized freeze-dried bone allografts for sinus augmentation revealed a mean of 29.1% 
newly formed bone and graft particles were mainly in close contact with newly formed 
bone, primarily with features of mature bone with numerous osteocytes (Kolerman et al., 
2008). Similar results were achieved with other reports that most of the specimens presented 
newly formed bone, and the interface areas between new and old bone were not discernible 
(Stacchi et al., 2008). There was no evidence of an acute inflammatory infiltrate in both 
studies (Kolerman et al., 2008; Stacchi et al., 2008). 
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However, histological evaluation revealed a chronic inflammatory reaction when 
demineralized freeze-dried bone was used in sinus augmentation, and the authors 
suggested that demineralized freeze-dried bone homografts may not be recommended to be 
used alone (Haas et al., 2002). 
2.3 Xenograft 
Deproteinized bovine bone is one of the most widely researched grafting materials and is 
used in the maxillofacial region because of its similarity to human (Hallman and Thor 2008). 
The complete absence of protein has been demonstrated, and its safety with respect to 
transmission of disease has been confirmed (Norton et al., 2003). Deproteinized cancellous 
bovine bone was placed as a grafting material for sinus floor elevation and histologic 
evaluation was performed after 6 months of healing (Valentini et al., 1998). Histologic 
evaluation showed that, in the grafted area and the previously existing area of the sinus 
floor, the bone was primarily of lamellar structure and intimate contact between newly 
formed bone and the particles of the graft was present (Valentini et al., 1998). 
Dental implants installed in sinuses augmented with xenograft showed bone-to-implant 
contact of 27% to 63%, and xenograft was shown to be very slowly restored and seemed to 
behave as a semipermanent grafting material (Wallace and Froum 2003). If xenograft is used 
with autogenous bone, this may give additional advantages such as an increase in the 
volume of the graft and longer space-maintaining effects due to prolonged resorption 
(Galindo-Moreno et al., 2007). 
2.4 Alloplastic materials 
Alloplastic materials consist of a large group of chemically diverse synthetic calcium-based 
biomaterials, including calcium sulfate, calcium phosphate, bioactive glasses, and polymers 
(Hallman and Thor 2008), and these bone substitutes possess osteoconductive properties 
(Moore et al., 2001).  
A study by Zijderveld, Zerbo, et al. showed that sinus augmentation using a limited volume 
of beta-tricalcium phosphate appeared to be a clinically reliable procedure, although 
autogenous bone grafting is still the gold standard (2005) (Zijderveld et al., 2005). This 
material is reported to act as an osteoconductive material and it allows osteoprogenitor cells 
to grow on its surface or into its porosity and differentiate into osteoblasts, thus bringing 
about bone deposition (Zerbo et al., 2005). 
Calcium sulfate hemihydrate has been proposed as a grafting material for sinus 
augmentation, and this resulted in good, new tissue formation within the sinuses when 
clinically and radiographically evaluated. The histomorphometiric analysis revealed bone 
density of 34.3% to 55.54% (De Leonardis and Pecora 2000). Similar results were achieved by 
other investigators (Pecora et al., 1998), and the study done at two years revealed new 
irregular trabecular design was seen radiographically and revealed normal, vital trabecular 
bone with woven and lamellar structure in all the histollogically examined sections 
(Guarnieri et al., 2006). 
2.5 Titanium granule 
Resorption of grafting material may lead to unpredictable long-term results when 
rehabilitating the resorbed posterior maxilla. Nonresorbable, osteoconductive bone substitutes 
may therefore be an advantage over autogenous bone grafts. Titanium granules were used as 
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bone substitute in patients scheduled to receive augmentation of the sinus floor prior to or in 
conjunction with placement of dental implants (Bystedt and Rasmusson 2009). 
3. Growth factors and the cell-based approach 
3.1 Platelet-rich plasma  
The use of platelet-rich plasma to enhance bone regeneration has been documented in 
periodontal defects, in extraction sockets, during implant placement, and in guided bone 
regeneration procedures around implants, including sinus augmentation (Kim et al., 2002). 
The use of platelet-rich plasma in conjunction with autogenous bone graft materials has been 
advocated for use in sinus augmentation surgery as a means of enhancing both quantity and 
quality of newly forming bone (Danesh-Meyer et al., 2001). The use of platelet-rich plasma is 
based on the premise that autogenous plasma, rich in platelets, contributes large quantities of 
mitogenic polypeptides such as platelet-derived growth factor, transforming growth factor-
beta and insulin-like growth factor-I, thereby enhancing osteogenesis, improving soft tissue 
healing, and reducing postoperative morbidity (Danesh-Meyer et al., 2001; Boyapati and Wang 
2006; Browaeys et al., 2007). The handling of the particulate bone grafts is reported to be 
improved due to the adhesive capacity of platelet-rich plasma via its hemostatic capacity of 
fibrin (Galindo-Moreno et al., 2007; Arora et al., 2010). 
In some reports, sinus augmentations were performed successfully with greater bone 
maturation when using a composite graft of cortical autogenous bone, bovine bone, and 
platelet-rich plasma (Galindo-Moreno et al., 2007). A randomized clinical trial was performed 
to test the efficacy of platelet-rich plasma in sinus augmentation procedures (Badr et al., 2010). 
No appreciable clinical effect could be observed when using platelet-rich plasma with 
autologous iliac crest bone graft in the maxilla. No statistically significant differences were 
observed for soft tissue healing indices (P=0.4) and mean graft resorption (P=0.5) between 
groups (autogenous bone only vs. bone + platelet-rich plasma). The findings suggest that the 
addition of platelet-rich plasma to bone derivative/substitute materials may not significantly 
enhance bone formation in the maxillary sinus area (Danesh-Meyer et al., 2001). 
The results from the other study showed that the marginal bone level measurements 
showed no significant differences, although there was a tendency toward less resorption on 
platelet-rich plasma sides. Resonance frequency analysis measurements showed statistically 
significantly higher implant stability quotient values for platelet-rich plasma sites at 
abutment connectios in the anterior but not in the posterior regions (Thor et al., 2005). 
Theoretically, it seems to have significant beneficial effects on the soft and hard tissue 
healing; however, the disparity in study design, surgical techniques, and different outcome 
assessment variables used makes it difficult to assess the practical benefit of its clinical use 
(Arora et al., 2010). Although platelet-rich plasma has been extensively studied for over a 
decade, there are no definitive reports proving the benefit of using platelet-rich plasma in 
sinus augmentation procedures (Arora et al., 2010). Therefore, the use of platelet-rich 
plasma may not be recommended as a standard method to support bone regeneration for 
maxillary sinus augmentation (Schaaf et al., 2008). 
3.2 Platelet rich fibrin  
Platelet-rich fibrin, a second-generation platelet concentrate, is a leucocyte- and platelet-rich 
fibrin biomaterial (Dohan Ehrenfest et al., 2009). Platelet-rich fibrin belongs to a new 
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generation of platelet concentrates characterized by simplified processing and without 
biochemical blood handling (Dohan et al., 2006). Platelets are activated during platelet-rich 
fibrin processing by centrifugation, and massive degranulation allows the release of 
cytokine (Mazor et al., 2009). Platelet-rich fibrin is reported to release transforming growth 
factor-beta1, platelet-derived growth factor-AB and vascular endothelial growth factor up to 
the whole experimental time (Dohan Ehrenfest et al., 2009). Slow fibrin polymerization 
during platelet-rich fibrin processing leads to the intrinsic incorporation of platelet cytokines 
and glycanic chains in the fibrin meshes (Mazor et al., 2009). Thus, results showed that 
platelet-rich fibrin, unlike the other platelet concentrates, would be able to progressively 
release cytokines during fibrin matrix remodeling, leading enhanced healing properties in 
experimental and clinical situations (Dohan et al., 2006). 
Platelet-rich fibrin was used in sinus augmentation procedures both in lateral and crestal 
approaches. In the lateral approach, platelet-rich fibrin was applied with or without the 
graft material, and the use of autogenous bone in combination with platelet-rich fibrin glue 
as a grafting material for maxillary sinus augmentation with simultaneous implant 
placement was tested in dogs (Lee et al., 2007). The results showed that the use of 
autogenous bone mixed with platelet-enriched fibrin glue can achieve results superior to 
those for grafts of autogenous bone alone in terms of enhanced osseointegration of dental 
implants (40.5±14.4% vs. 32.3±12.0%) and increased height of new bone (12.0±1.0% vs. 
10.7±1.0%) (Lee et al., 2007). 
Other studies used no bone substitutes, and the biopsies were taken in the center of the 
regenerated osteotomy window of the sinus lift. Therefore, all of the observed bone must be 
considered new bone built starting from the sole platelet-rich fibrin matrix (Mazor et al., 
2009). All biopsies showed well-organized and vital bone, often with more than 30% bone 
matrix (33% ± 5%). 
Osteotome-mediated sinus floor elevation was performed using only platelet-rich fibrin, and 
of the 138 implants that had been placed, 97 have been restored function for an average 
loading time of 5.2 months with a survival rate of 97.8% (Toffler et al., 2010). Early review of 
the osteotome-mediated sinus floor elevation with platelet-rich fibrin technique presented for 
localized sinus floor elevation and implant placement demonstrates a high degree of safety 
and success at sites with 5- to 8-mm residual subantral bone height (Toffler et al., 2010). 
3.3 Bone morphogenetic protein  
Growth factors are present at low concentrations in bone matrix and plasma, but they 
execute important biologic functions (Hallman and Thor 2008). The growth factors are 
believed to have an osseous regenerative effect on the mesenchymal stem cells and 
contribute to cellular proliferation, matrix formation, collagen synthesis, and osteoid 
production (Yamada et al., 2008). Bone morphogenetic proteins are multi-functional growth 
factors belonging to the transforming growth factor-beta superfamily, and bone 
morphogenetic proteins are reported to have a variety of functions (Wang et al., 1990; Xiao 
et al., 2007). Bone morphogenetic protein molecules not only induce the formation of both 
cartilage and bone but also play a role in a number of non-osteogenic developmental 
processes (Xiao et al., 2007), and they are capable of inducing ectopic cartilage and bone 
formation, a process that mimics embryonic endochondral bone formation (Xiao et al., 2007). 
Bone morphogenetic protein 2, 4 and 7, in particular, are reported to be the most effective 
growth factors in terms of osteogenesis and osseous defect repair (Schilephake 2002), and 
three bone morphogenetic proteins— bone morphogenetic protein 2, 7, and 14—have been 
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applied in sinus augmentation procedures (Park 2009). The efficacy of Bone morphogenetic 
proteins for defect repair is strongly dependent on the type of carrier and has been subject to 
unknown factors in clinical feasibility trials resulting in ambiguous results. 
Autogenous bone graft demonstrated greater increases in mineralization and probably 
angiogenesis of bone than the other bioimplants in rabbit sinus augmentation models when 
bone morphogenetic protein was delivered at the same time (Hu et al., 2010). 
The effectiveness of recombinant human bone morphogenetic protein-2 on an absorbable 
collagen sponge was compared with an autogenous bone graft when used for two-stage 
maxillary sinus floor augmentation (Triplett et al., 2009). No marked differences were found 
in the histologic parameters evaluated between the two groups, but the induced bone in the 
recombinant human bone morphogenetic protein-2/absorbable collagen sponge group was 
significantly denser than that in the bone graft group (Triplett et al., 2009). Additionally, 
collagen sponge was shown to induce new bone equally as well as the other composite 
material when loaded with bone morphogenetic protein (Pekkarinen et al., 2005). The effects 
of mineralized bone replacement grafts (e.g., xenografts and allografts) on recombinant 
human bone morphogenetic protein-2/absorbable collagen sponge were tested, and bone 
graft densities tended to increase more with the xenograft than with the allograft (Tarnow et 
al., 2010). The increased density in allograft cases was likely the result of both compression 
of the mineralized bone replacement graft and vital bone formation, seen histologically 
(Tarnow, Wallace, et al., 2010). Loss of volume was greater with the four-sponge dose than 
the two-sponge dose because of compression, and resorption of the sponges and vital bone 
formation in the allograft cases ranged from 36% to 53% (Tarnow et al., 2010). 
Hydroxyapatite, biphasic tri-calcium phosphate-hydroxyapatite, and natural coral are 
reported to be equally good as framing material for bone morphogenetic protein 
(Pekkarinen et al., 2005).  
Deproteinized bovine bone mineral is known to show excellent osteoconductive properties, 
and it has been used for sinus augmentation clinically (Terheyden et al., 1999). The bovine 
xenograft composite promotes formation of new bone in a similar fashion to autogenous 
bone when bone morphogenetic proteins were bound to the graft material, and could 
therefore be considered a biomaterial with potential applications as a bone substitute in 
maxillary sinus floor augmentation (Sicca et al., 2008). 
It has been shown that beta-tricalcium phosphate is suitable as a biodegradable, highly 
biocompatible, and osteoconductive carrier for bone morphogenetic proteins in sinus 
augmentation procedures (Gruber et al., 2008). Both experimentally and clinically, 
recombinant human bone morphogenetic protein-14/beta-tricalcium phosphate was found 
to be effective and safe as the control treatment with autologous bone mixed with beta-
tricalcium phosphate in sinus floor augmentation (Koch et al., 2010). Self-setting alpha-
tricalcium phosphate was used in maxillary sinus augmentation, and it was shown to have 
bone-conductive activity and shown to maintain the rigidity of implanted bone screws 
(Marukawa et al., 2010).  
Composite material has been used for bone morphogenetic protein-2 release in mandibular 
defect areas (Wen, Karl, et al., 2011). While in-vitro bone morphogenetic protein-2 release 
was highest for the polyethylene glycol hydrogel, the scaffold most successful in vivo was 
the collagen-hydroxyapatite composite infused with polyethylene glycol-hydrogel scaffold 
because it had the necessary mechanical strength to perform well in the mandibular bone 
environment (Wen et al., 2011). The in vitro release studies suggested a threshold dose of 5 
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μg that was confirmed by the in vivo dose response studies (Wen, Karl, et al., 2011). Many 
studies have demonstrated the potential for the bone morphogenetic proteins to increase 
bone formation in sinus augmentation procedures and further studies are warranted to find 
an appropriate carrier scaffold for the optimal release of bone morphogenetic proteins (Park 
2009). 
Bone morphogenetic protein-7 was loaded onto a poloxamer carrier or demineralized bone 
matrix in a poloxamer carrier (Ho et al., 2010). These bioimplants had more rapid initial 
bone production than all other materials, including autogenous bone, and these bone 
morphogenetic protein-containing bioimplants demonstrated promise as alternatives to 
autogenous bone grafts for sinus-augmentation procedures (Ho et al., 2010). 
In the future, such biomaterials may enable earlier placement of dental implants into 
augmented maxillary sinuses. 
3.4 Platelet-derived growth factor  
Platelet-derived growth factor plays an important role in inducing proliferation of 
undifferentiated mesenchymal cells (Schilephake 2002); it is a stimulator of the proliferation 
and recruitment of both bone cells and periodontal ligaments (Nevins et al., 2003). It is an 
important mediator for bone healing and remodeling during trauma and infection, and it is 
reported to enhance bone regeneration in conjunction with other growth factors 
(Schilephake 2002). 
Recombinant human platelet-derived growth factor-BB was used in simultaneous vertical 
guided bone regeneration and guided tissue regeneration in the posterior maxilla (Urban et 
al., 2009). The results demonstrated successful use of recombinant human platelet-derived 
growth factor-BB in conjunction with autogenous bone, anorganic bone mineral, and barrier 
membranes to reconstruct severe alveolar bone defects (Urban et al., 2009). A significant 
amount of periodontal bone gain was achieved in close apposition to a previously denuded 
root surface, giving the possibility of vertical periodontal regeneration (Urban et al., 2009). 
The use of purified recombinant human platelet-derived growth factor-BB mixed with bone 
allograft in humans is reported to result in periodontal regeneration in both Class II 
furcations and interproximal intrabony defects in human Class II furcation defects (Nevins 
et al., 2003). 
The regenerative outcomes in maxillary sinus augmentation procedures were tested when 
recombinant human platelet-derived growth factor-BB was combined with particulate 
anorganic bovine bone mineral (Nevins et al., 2009). The surgical outcomes in all treated 
sites were uneventful at 6 to 8 months, with sufficient regenerated bone present. Large areas 
of dense, well-formed lamellar bone were seen throughout the intact core specimens, and a 
number of cores demonstrated efficient replacement of the normally slowly resorbing 
anorganic bovine bone mineral matrix particles with newly formed bone. 
3.5 Mesenchymal stem cell  
Long-term success of dental implants has been demonstrated when placed simultaneously 
with or after a sinus augmentation procedure (Gonshor et al., 2011). However, optimal bone 
formation can be from 6 to 9 months or longer with grafting materials other than 
autogenous bone (Pieri et al., 2008). Various osteoconductive materials have been applied to 
augment the sinus floor, but these materials are cell-free and may require more time for 
bone healing (Pieri et al., 2008). 
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Bone marrow contains a population of rare progenitor cells capable of differentiating into 
bone, cartilage, tendon, and other connective tissues, and these mesenchymal stem cells can 
be purified and culture-expanded from animals and humans and have been shown to 
regenerate functional tissue when delivered to the site of musculoskeletal defects in 
experimental animals (Bruder et al., 1998). Cells can be also be achieved intraorally from the 
maxillary tuberosity and the periosteum of the mandible (Turhani et al., 2005; Springer et 
al., 2006) The study was done to assess whether differences occur in bone formation after 
maxillary sinus floor elevation surgery with bovine bone mineral mixed with autogenous 
bone or autogenous stem cells (Rickert et al., 2010). Mesenchymal stem cellseeded on 
xenograft particles can induce the formation of a sufficient volume of new bone to enable 
the reliable placement of implants within a time frame comparable to that of applying either 
solely autogenous bone or a mixture of autogenous bone and xenograft; this technique could 
be an alternative to using autografts (Rickert et al., 2010). 
Sinus augmentation procedures using either an allograft cellular bone matrix, containing 
native mesenchymal stem cells and osteoprogenitors, or conventional allograft showed 
similar results (Gonshor et al., 2011). Histomorphometric analysis of the allograft cellular 
bone matrix grafts revealed average vital bone content of 32.5% ± 6.8%, but results for the 
conventional allograft showed an average vital bone content of 18.3% ± 10.6% at an average 
healing period of 3.7 ± 0.6 months (Gonshor et al., 2011). 
An ovine split-mouth study was applied to compare bovine bone mineral alone and in 
combination with mesenchymal stem cells regarding their potential in sinus augmentation 
(Sauerbier et al., 2010). The authors concluded that the high percentage of vital bone content, 
after a relatively short healing phase, may encourage a more rapid initiation of implant 
placement or restoration when a cellular grafting approach is considered (McAllister et al., 
2009; Sauerbier et al., 2010). 
4. Conclusion 
Sinus augmentation procedures have been used clinically with very high success rates. 
Bone-substitute materials are reported to be as effective as autogenous bone when used 
alone or in combination with autogenous bone. It may be concluded that bone substitutes 
can be successfully used for sinus augmentation, reducing donor-site morbidity. Attempts 
have been made to accelerate bone formation with different scaffolds, growth factors, and 
mesencymal stem cells. Further studies are needed to find an optimal approach that can 
enhance bone formation in sinus augmentation procedures. 
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